Short-term treatment with 60 mg or 30 mg per day of prednisolone, a type of corticosteroid, did not appear to lower glucose tolerance in rheumatoid arthritis patients, including those with impaired glucose metabolism or type 2 diabetes. The study in Arthritis & Rheumatism also found that patients who took prednisolone had improvements in C-reactive protein levels and, for those on the 60 mg per day dose, improved beta cell function.

Full Story:

Related Summaries